India, Aug. 2 -- What separates the pharmaceutical companies that will shape the future of healthcare from those that merely keep up with it? For a long time, the honest answer was scale, the size of a plant, the volume it could ship, and the price at which it could ship it. Today, the answer lies somewhere quieter and far harder to copy: the strength of a company's research and development. As discovery accelerates, innovation has become the industry's most valuable currency, and R&D the engine that mints it.

For most of its history, pharmaceutical manufacturing was defined by four things, scale, quality, regulatory compliance and cost efficiency. Master them, and you lead. They still matter, but they no longer decide the winners. The r...